Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, pp.359-86, 2015. ,
Lymph node count from neck dissection predicts mortality in head and neck cancer, J Clin Oncol, 2016. ,
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer, N Engl J Med, vol.350, pp.1945-1952, 2004. ,
Malignant transformation of oral leukoplakia: a systematic review of observational studies, J Oral Pathol Med, vol.45, pp.155-166, 2016. ,
Is there any benefit in surgery for potentially malignant disorders of the oral cavity?, J Oral Pathol Med, vol.43, pp.239-244, 2014. ,
Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment, Nat Med, vol.2, pp.682-685, 1996. ,
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia, Clin Cancer Res, vol.6, pp.357-362, 2000. ,
Loss of heterozygosity (LOH) profiles-validated risk predictors for progression to oral cancer, Cancer Prev Res (Phila), vol.5, pp.1081-1089, 2012. ,
Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer, Cancer Prev Res (Phila), vol.3, pp.800-809, 2010. ,
Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemicallyinduced mouse model of oral squamous cell carcinoma, Cancer Prev Res (Phila), vol.4, pp.230-237, 2011. ,
Oral Cancer Chemoprevention-the End of EPOC, the beginning of an epoch of molecular selection, JAMA Oncol, vol.2, pp.178-179, 2016. ,
Pilot randomized phase II study of celecoxib in oral premalignant lesions, Clin Cancer Res, vol.14, pp.2095-2101, 2008. ,
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy, J Clin Oncol, vol.27, pp.599-604, 2009. ,
Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis, N Engl J Med, vol.328, pp.15-20, 1993. ,
Erlotinib and the risk of oral cancer: the erlotinib prevention of oral cancer (EPOC) randomized clinical trial, JAMA Oncol, vol.2, pp.209-216, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01796193
13-cisretinoic acid in the treatment of oral leukoplakia, N Engl J Med, vol.315, pp.1501-1505, 1986. ,
Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial, Cancer Prev Res (Phila), vol.6, pp.410-418, 2013. ,
Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes, PLoS One, vol.8, p.56823, 2013. ,
, Comprehensive genomic characterization of head and neck squamous cell carcinomas, Cancer Genome Atlas N, vol.517, pp.576-582, 2015.
Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes, Clin Cancer Res, vol.21, pp.870-881, 2015. ,
Head and neck cancer subtypes with biological and clinical relevance: meta-analysis of geneexpression data, Oncotarget, vol.6, pp.9627-9642, 2015. ,
A 13-gene expressionbased radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes, BMC Med, vol.15, p.165, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01589514
Gene expression profiling predicts the development of oral cancer, Cancer Prev Res (Phila), vol.4, pp.218-229, 2011. ,
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, vol.102, pp.15545-15550, 2005. ,
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1, Nature, vol.462, pp.108-112, 2009. ,
GenePattern 2.0, Nat Genet, vol.38, pp.500-501, 2006. ,
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression ,
URL : https://hal.archives-ouvertes.fr/hal-01398093
, Genome Biol, vol.17, p.218, 2016.
DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia, Clin Cancer Res, vol.15, pp.6284-6291, 2009. ,
microRNAs and the immune response, Curr Opin Pharmacol, vol.9, pp.514-520, 2009. ,
MicroRNAs regulatory networks in myeloid lineage development and differentiation: regulators of the regulators, Immunol Cell Biol, vol.90, pp.587-593, 2012. ,
MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development, Crit Rev Immunol, vol.33, pp.435-476, 2013. ,
3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites, Cancer Res, vol.62, pp.6447-6450, 2002. ,
Precancer atlas to drive precision prevention trials, Cancer Res, vol.77, pp.1510-1541, 2017. ,
Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types, Clin Cancer Res, vol.16, pp.4864-4875, 2010. ,
A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis, Clin Cancer Res, vol.17, pp.1490-1501, 2011. ,
A patient-derived, pan-cancer emt signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition, Clin Cancer Res, vol.22, pp.609-620, 2016. ,
Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer, Cell, vol.171, pp.1611-1635, 2017. ,
The immune landscape of cancer. Immunity, vol.48, pp.812-842, 2018. ,
Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma, Hum Mol Genet, vol.18, pp.4818-4829, 2009. ,
miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program, Nat Commun, vol.6, p.8523, 2015. ,
Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma, J Natl Cancer Inst, issue.8, p.106, 2014. ,
Leveraging premalignant biology for immune-based cancer prevention, Proc Natl Acad Sci U S A, vol.113, pp.10750-10758, 2016. ,
Nivolumab for recurrent squamous-cell carcinoma of the head and neck, N Engl J Med, 2016. ,
Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohort, J Clin Oncol, 2016. ,
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial, Lancet Oncol, issue.16, pp.30066-30069, 2016. ,
Oncogenic growth factor signaling mediating tumor escape from cellular immunity, Curr Opin Immunol, vol.45, pp.52-59, 2017. ,
An inflammatory cytokine milieu is prominent in premalignant oral lesions, but subsides when lesions progress to squamous cell carcinoma, J Clin Cell Immunol, vol.5, issue.3, p.230, 2014. ,
Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: implications for patients with oral precancerous lesions, Oral Oncol, vol.68, pp.36-43, 2017. ,
Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers, Clin Cancer Res, vol.12, pp.465-472, 2006. ,
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma, Head Neck, vol.38, pp.1074-1084, 2016. ,
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer, Br J Cancer, vol.110, pp.501-509, 2014. ,
The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer, Oncotarget, 2016. ,
Premalignant oral lesion cells elicit increased cytokine production and activation of T-cells, Anticancer Res, vol.36, pp.3261-3270, 2016. ,
Immune-mediated antitumor effect by type 2 diabetes drug, metformin, Proc Natl Acad Sci U S A, vol.112, pp.1809-1814, 2015. ,
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking ,
, Bioinformatics, vol.26, pp.1572-1573, 2010.
Orchestrating highthroughput genomic analysis with Bioconductor, Nat Methods, vol.12, pp.115-121, 2015. ,
Exploration, normalization, and summaries of high density oligonucleotide array probe level data, Biostatistics, vol.4, pp.249-264, 2003. ,
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data, Nucleic Acids Res, vol.33, p.175, 2005. ,
miRNet -dissecting miRNA-target interactions and functional associations through network-based visual analysis, Nucleic Acids Res, vol.44, pp.135-176, 2016. ,
ForceAtlas2, a continuous graph layout algorithm for handy network visualization designed for the Gephi software, PLoS One, vol.9, issue.6, pp.1496880-1496892, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01908005